Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive
✍️ Marina Temkin, Kirsten Korosec, Aria Alamalhodaei, Julie Bort, Amanda Silberling, Techcrunch Events, .Post-Authors-List__Authors --Font-Size Var, Align-Items Center Display Flex Gap Var, .Post-Authors-List__Authors .Post-Authors-List__Author-Thumbs Display Flex Flex-Shrink Margin Padding .Post-Authors-List__Authors .Post-Authors-List__Author-Thumbs Li List-Style None Margin-Left Margin-Top Important .Post-Authors-List__Authors .Post-Authors-List__Author-Thumbs Li First-Child Margin-Left .Post-Authors-List__Authors .Post-Authors-List__Author-Thumbs .Post-Authors-List__Author-Thumb Background-Color Var, Border Solid Var --Wp--Custom--Color--White📅 March 31, 2025 12:00 AM🕐 Scraped: October 01, 2025
Summary: Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
In Brief
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised external capital for the first time.
📰
Continue Reading on TechCrunch
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.